HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Neal E Slatkin Selected Research

Opioid-Induced Constipation

1/2022First-Dose Efficacy of Methylnaltrexone in Patients with Severe Medical Illness and Opioid-Induced Constipation: A Pooled Analysis.
9/2021The influence of brain metastases on the central nervous system effects of methylnaltrexone: a post hoc analysis of 3 randomized, double-blind studies.
6/2021Correction to: The Influence of Age on Central Effects of Methylnaltrexone in Patients with Opioid-Induced Constipation.
1/2021The Influence of Age on Central Effects of Methylnaltrexone in Patients with Opioid-Induced Constipation.
1/2021Attrition of methylnaltrexone treatment-emergent adverse events in patients with chronic noncancer pain and opioid-induced constipation: a post hoc pooled analysis of two clinical trials.
1/2021Subcutaneous Methylnaltrexone for Treatment of Opioid-Induced Constipation in Cancer versus Noncancer Patients: An Analysis of Efficacy and Safety Variables from Two Studies.
3/2020Subcutaneous methylnaltrexone for opioid-induced constipation in advanced-illness patients with or without active cancer.
1/2019Safety of oral methylnaltrexone for opioid-induced constipation in patients with chronic noncancer pain.
1/2017Randomized, Double-Blind Trial of Oral Methylnaltrexone for the Treatment of Opioid-Induced Constipation in Patients with Chronic Noncancer Pain.
7/2015Efficacy and Tolerability of Subcutaneous Methylnaltrexone in Patients with Advanced Illness and Opioid-Induced Constipation: A Responder Analysis of 2 Randomized, Placebo-Controlled Trials.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Neal E Slatkin Research Topics

Disease

15Pain (Aches)
01/2022 - 01/2003
12Opioid-Induced Constipation
01/2022 - 05/2008
10Neoplasms (Cancer)
01/2022 - 01/2003
5Nausea
01/2021 - 05/2007
4Constipation
01/2021 - 05/2008
4Cancer Pain
05/2010 - 11/2003
3Substance Withdrawal Syndrome (Withdrawal Symptoms)
09/2021 - 03/2020
3Abdominal Pain (Pain, Abdominal)
01/2019 - 11/2011
2Vomiting
01/2021 - 05/2007
2Breakthrough Pain
07/2010 - 07/2007
2Chronic Pain
09/2009 - 07/2007
2Breast Neoplasms (Breast Cancer)
09/2005 - 01/2004
1Brain Neoplasms (Brain Tumor)
09/2021
1Dementia (Dementias)
01/2021
1Stroke (Strokes)
01/2021
1Cardiotoxicity
01/2019
1Diarrhea
01/2019
1Flatulence
07/2015
1Muscle Cramp (Cramp)
11/2011
1Body Weight (Weight, Body)
05/2008
1Dizziness (Lightheadedness)
07/2007
1Fatigue
07/2007
1Peripheral Nervous System Diseases (PNS Diseases)
01/2004
1Mucositis
09/2003
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
09/2003
1Sleepiness
05/2003
1Sleep Initiation and Maintenance Disorders (Insomnia)
05/2003
1Weight Loss (Weight Reduction)
05/2003
1Alzheimer Disease (Alzheimer's Disease)
05/2003
1Death (Near-Death Experience)
01/2003
1Intractable Pain
01/2003

Drug/Important Bio-Agent (IBA)

13Opioid Analgesics (Opioids)IBA
01/2022 - 07/2007
12methylnaltrexoneFDA Link
01/2022 - 05/2008
4Narcotic Antagonists (Opioid Antagonists)IBA
09/2021 - 01/2017
4Morphine (MS Contin)FDA LinkGeneric
01/2021 - 07/2015
3LaxativesIBA
01/2022 - 01/2019
3Opiate AlkaloidsIBA
09/2003 - 01/2003
2Opioid Receptors (Opioid Receptor)IBA
01/2021 - 05/2008
2TabletsIBA
07/2010 - 07/2007
2Fentanyl (Sublimaze)FDA LinkGeneric
07/2010 - 07/2007
2Paclitaxel (Taxol)FDA LinkGeneric
09/2005 - 01/2004
2KetamineFDA LinkGeneric
11/2003 - 09/2003
1Analgesics (Analgesic Drugs)IBA
01/2021
1Oxymorphone (Numorphan)FDA LinkGeneric
05/2010
1Dopamine AntagonistsIBA
05/2007
1CannabinoidsIBA
05/2007
1Serotonin (5 Hydroxytryptamine)IBA
05/2007
1Neurotransmitter Agents (Neurotransmitter)IBA
05/2007
1Neuroprotective AgentsIBA
01/2004
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2004
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2004
1Amifostine (Ethyol)FDA LinkGeneric
01/2004
1Methylphenidate (Ritalin)FDA LinkGeneric
05/2003
1AcetylcholinesteraseIBA
05/2003
1Donepezil (Aricept)FDA LinkGeneric
05/2003
1Phenol (Carbolic Acid)FDA Link
01/2003

Therapy/Procedure

7Analgesia
01/2022 - 07/2007
3Therapeutics
07/2010 - 09/2008
2Pain Management
01/2021 - 01/2003
1Palliative Care (Palliative Therapy)
09/2008
1Drug Therapy (Chemotherapy)
05/2007
1Radiotherapy
09/2003